SK Biopharmaceuticals. (326030.KQ) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
192
901
1,609
2,318

Details

Expected EPS
349
Actual EPS
929
Surprise EPS
580
Surprise Percent
+166.12%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 929 per share for Q4 2025.

0 Comments

Share your thoughts